Goertz, Lukas
Al-Sewaidi, Yosef
Habib, Mahmoud
Zopfs, David
Reichardt, Benjamin
Ranft, Alexander
Kabbasch, Christoph
Article History
Received: 11 October 2023
Accepted: 16 March 2024
First Online: 12 April 2024
Declarations
:
: C. Kabbasch serves as consultant for Acandis GmbH (Pforzheim, Germany) and as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). D. Zopfs is on the speaker’s bureau of Philips (Amsterdam, the Netherlands) and lecturer for Amboss GmbH (Cologne, Germany). L. Goertz, Y. Al-Sewaidi, M. Habib, B. Reichardt and A. Ranft declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The study was conducted in accordance with the STROBE guidelines in compliance with the national legislation and the Code of Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association (Declaration of Helsinki). Informed consent was obtained from all individual participants included in the study.
: The supplement containing this article is not sponsored by industry.